GTMRX
Price
$18.74
Change
+$0.22 (+1.19%)
Updated
Jul 25 closing price
Net Assets
1.47B
PMBPX
Price
$47.20
Change
+$0.33 (+0.70%)
Updated
Jul 25 closing price
Net Assets
33.21B
Interact to see
Advertisement

GTMRX vs PMBPX

Header iconGTMRX vs PMBPX Comparison
Open Charts GTMRX vs PMBPXBanner chart's image
Goldman Sachs Small/Mid Cap Growth R
Price$18.74
Change+$0.22 (+1.19%)
VolumeN/A
Net Assets1.47B
Principal MidCap R5
Price$47.20
Change+$0.33 (+0.70%)
VolumeN/A
Net Assets33.21B
GTMRX vs PMBPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GTMRX vs. PMBPX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTMRX is a StrongBuy and PMBPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBPX has more cash in the bank: 33.2B vs. GTMRX (1.47B). PMBPX pays higher dividends than GTMRX: PMBPX (0.01) vs GTMRX (0.00). GTMRX was incepted earlier than PMBPX: GTMRX (18 years) vs PMBPX (25 years). GTMRX (1.53) is less costly to investors than PMBPX (0.83). GTMRX is a more actively managed with annual turnover of: 69.00 vs. PMBPX (10.50). GTMRX (0) and PMBPX (0) have matching initial minimum investment requirements. PMBPX annual gain was more profitable for investors over the last year : 13.61 vs. GTMRX (0.54). PMBPX return over 5 years is better than : 56.25 vs. GTMRX (-10.25).
GTMRXPMBPXGTMRX / PMBPX
Total Expense Ratio1.490.83180%
Annual Report Gross Expense Ratio1.530.83184%
Fund Existence18 years25 years-
Gain YTD-3.0028.606-35%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.47B33.2B4%
Annual Yield % from dividends0.000.01-
Returns for 1 year0.5413.614%
Returns for 3 years23.8649.3848%
Returns for 5 years-10.2556.25-18%
Returns for 10 years-13.56107.27-13%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TKO170.052.05
+1.22%
TKO Group Holdings
OCSL14.460.13
+0.91%
Oaktree Specialty Lending Corp
IQST9.450.04
+0.43%
Iqstel Inc
HOVNP19.16-0.07
-0.34%
Hovnanian Enterprises
RNAC13.33-0.13
-0.97%
Cartesian Therapeutics